Yogic Breathing and IBS
Effects of Yogic Breathing on Microvascular Endothelial Function and Symptoms in Participants With IBS
1 other identifier
interventional
14
1 country
1
Brief Summary
Adults with irritable bowel syndrome (IBS) are being randomized to a yogic breathing or control condition. Participants randomized to the yogic breathing group will be asked to complete a 2-minute yogic breathing video 5 to 7 days per week at home for 4 weeks and control group participants will be asked to maintain their current activities. Participants in this group will be given access to the yogic breathing video at the end of the 4-week control period. IBS symptoms and autonomic and vascular function will be assessed at baseline and at the end of week 4 in both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2019
CompletedFirst Submitted
Initial submission to the registry
January 7, 2020
CompletedFirst Posted
Study publicly available on registry
January 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedAugust 6, 2021
March 1, 2021
10 months
January 7, 2020
July 31, 2021
Conditions
Outcome Measures
Primary Outcomes (11)
IBS Symptoms
IBS-Symptom Severity Scale will be administered.
Once at baseline
IBS Symptoms
IBS-Symptom Severity Scale will be administered.
Once at the end of week 2
IBS Symptoms
IBS-Symptom Severity Scale will be administered.
Once at the end of week 4
Autonomic function
Heart rate variability will be assessed.
Once at baseline
Autonomic function
Heart rate variability will be assessed.
Once at the end of week 2
Autonomic function
Heart rate variability will be assessed.
Once at the end of week 4
Autonomic function
Exercise heart rate recovery will be measured.
Once at baseline
Autonomic function
Exercise heart rate recovery will be measured.
Once at the end of week 2
Autonomic function
Exercise heart rate recovery will be measured.
Once at the end of week 4
Microvascular function
Laser Doppler flowmetry at baseline and in response to local heating will be measured.
Once at baseline
Microvascular function
Laser Doppler flowmetry and in response to local heating will be measured.
Once at the end of week 4
Study Arms (2)
Yogic breathing intervention
EXPERIMENTALParticipants assigned to this group will complete a 20-minute yogic breathing video at least 5 days per week for 4 weeks. All sessions except the initial yogic breathing session will be completed at home. Participants will complete the first session at Texas State under the supervision of the investigative team for familiarization.
Control
NO INTERVENTIONParticipants in the control group will be asked to maintain their current daily activities and will be given access to the yogic breathing video once all follow-up testing has been completed at the end of week 4.
Interventions
Yogic breathing will be completed while following a video provided by the investigative team. Breathing practices consist of slow, deep, relaxation breathing and are led by a certified yoga instructor.
Eligibility Criteria
You may qualify if:
- Must have a formal diagnosis of IBS and not be enrolled in any other clinical trials.
You may not qualify if:
- \) current, regular practice of yogic breathing at least 5 minutes per day and 2) chronic obstructive pulmonary disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stacy Hunter
San Marcos, Texas, 78666, United States
Related Publications (1)
Katherine Jurek M, Seavey H, Guidry M, Slomka E, Hunter SD. The effects of slow deep breathing on microvascular and autonomic function and symptoms in adults with irritable bowel syndrome: A pilot study. Neurogastroenterol Motil. 2022 May;34(5):e14275. doi: 10.1111/nmo.14275. Epub 2021 Oct 1.
PMID: 34595801DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stacy D Hunter, PhD
Texas State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Members of the investigative team will be blinded to the participant's group assignment until all testing is completed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2020
First Posted
January 13, 2020
Study Start
April 15, 2019
Primary Completion
February 1, 2020
Study Completion
March 1, 2020
Last Updated
August 6, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share